Fig. 5
From: A review on the advances and challenges of immunotherapy for head and neck cancer
Therapeutic vaccines against cancer. Following the administration, the tumor antigens are uptaken and processed by antigen-presenting cells (APCs) to present on major histocompatibility complex (MHC) classes to T-cells and activate them against the antigen